Drug Companies Have More Than $500 Billion To Spend – And These 22 Companies Could Be Their Targets
After a slow start to the year, merger and acquisition activity in the drug industry could be about to pick up – especially with drug… Read More »Drug Companies Have More Than $500 Billion To Spend – And These 22 Companies Could Be Their Targets